Civic Intelligence

Amyotrophic Lateral Sclerosis Association

990 • Fiscal year 2013 • EIN 37-1667986

Feb 01, 2012 to Jan 31, 2013

Liverpool, NY
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

51st percentile

0.06x

Higher debt load relative to assets than 51% of similar nonprofits.

2013 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2013

Liabilities / Revenue

49th percentile

0.04x

Higher debt load relative to revenue than 49% of similar nonprofits.

2013 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2013

Net Margin

82nd percentile

27%

Higher net margin than 82% of similar nonprofits.

2013 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2013

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2013

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Assets

$369,410

No earlier filing loaded for comparison.

Net Assets

$347,597

No earlier filing loaded for comparison.

Liabilities

$21,813

No earlier filing loaded for comparison.

Revenue

$555,013

No earlier filing loaded for comparison.

Expenses

$403,398

No earlier filing loaded for comparison.

Net Income

$151,615

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$3.0M$2.0M$1.0M$0Assets 2013: $369,410Liabilities 2013: $21,813Net Assets 2013: $347,5972013Assets 2014: $525,437Liabilities 2014: $36,946Net Assets 2014: $488,4912014Assets 2015: $1,086,837Liabilities 2015: $17,663Net Assets 2015: $1,069,1742015Assets 2016: $1,266,661Liabilities 2016: $62,080Net Assets 2016: $1,204,5812016Assets 2017: $1,281,796Liabilities 2017: $93,598Net Assets 2017: $1,188,1982017Assets 2018: $1,502,472Liabilities 2018: $87,877Net Assets 2018: $1,414,5952018Assets 2019: $1,570,075Liabilities 2019: $51,970Net Assets 2019: $1,518,1052019Assets 2020: $1,787,541Liabilities 2020: $68,228Net Assets 2020: $1,719,3132020Assets 2021: $2,040,082Liabilities 2021: $68,030Net Assets 2021: $1,972,0522021Assets 2022: $2,245,425Liabilities 2022: $91,467Net Assets 2022: $2,153,9582022Assets 2023: $2,170,858Liabilities 2023: $89,230Net Assets 2023: $2,081,6282023

Highlighted filing

2013

Assets$369,410
Liabilities$21,813
Net Assets$347,597

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KRevenue 2013: $555,013Expenses 2013: $403,398Net Income 2013: $151,6152013Revenue 2014: $620,612Expenses 2014: $479,718Net Income 2014: $140,8942014Revenue 2015: $1,035,106Expenses 2015: $454,423Net Income 2015: $580,6832015Revenue 2016: $702,124Expenses 2016: $565,064Net Income 2016: $137,0602016Revenue 2017: $676,083Expenses 2017: $739,095Net Income 2017: -$63,0122017Revenue 2018: $920,141Expenses 2018: $757,895Net Income 2018: $162,2462018Revenue 2019: $960,017Expenses 2019: $842,468Net Income 2019: $117,5492019Revenue 2020: $1,075,944Expenses 2020: $947,373Net Income 2020: $128,5712020Revenue 2021: $1,001,847Expenses 2021: $865,760Net Income 2021: $136,0872021Revenue 2022: $1,082,289Expenses 2022: $922,518Net Income 2022: $159,7712022Revenue 2023: $1,095,012Expenses 2023: $1,089,830Net Income 2023: $5,1822023

Highlighted filing

2013

Revenue$555,013
Expenses$403,398
Net Income$151,615
Filing Detail Status

This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Feb 1, 2012 to Jan 31, 2013
Mission and Program Overview

Mission

Leading the fight to treat and cure als through global research and nationwide advocacy while also empowering people with lou gehrig's disease and their families to live fuller lives by providing them with compassionate care and support.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings